Clinical Trial Update: Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs. [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial update for RayzeBio's RYZ401 in subjects with solid tumors expressing somatostatin receptors; the study is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoid Tumor
• Gastroenteropancreatic Neuroendocrine Tumor
• Neuroendocrine Tumor
• Pancreatic Neuroendocrine Tumor

Drugs mentioned

• RYZ401

Snippet

Sponsor: RayzeBio, Inc. | Conditions: GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor | Phase 1 | Status: RECRUITING